Latest Breaking News On - Prnewswire redhill biopharma ltd - Page 15 : comparemela.com

RedHill Biopharma Announces Closing of $35 Million Bought Deal Offering of American Depositary Shares USA - English Share this article Share this article TEL AVIV, Israel and RALEIGH, N.C., March 4, 2021 /PRNewswire/ RedHill Biopharma Ltd. (Nasdaq: RDHL) ( RedHill or the Company ), a specialty biopharmaceutical company, today announced the closing of its previously announced underwritten public offering of 4,375,000 American Depositary Shares (ADSs) of the Company, at a price to the public of $8.00 per ADS. Each ADS represents ten ordinary shares, par value NIS 0.01 per share, of the Company. H.C. Wainwright & Co. acted as the sole book-running manager for the offering.

New yorkUnited statesBryan gibbsRedhill biopharmaAdi frishRedhill biopharma ltdExchange commissionCompany annual report on formAmerican depositary shares adss of the companyCompany expanded access programHc wainwright coCorporate business developmentPrnewswire redhill biopharma ltdHill biopharmaDepositary sharesPrivate securities litigation reform act